Pharmafile Logo
Pharmafocus logo
Advanced Search

GDP

Showing 8 posts of 8 posts found.

Spending graph

Emerging markets top global R&D spending league

February 4, 2016
Research and Development GDP, OECD, R&D spending, investment

Data from the Organisation for Economic Co-operation and Development (OECD) shows Korea and Israel are investing much more in research …

News
ema building

EMA identifies GMP transgressors in public database

January 6, 2014
Manufacturing and Production Database, EMA, GDP, GMP

The European Medicines Agency has continued its march towards increased transparency by publishing – for the first time – the …

News
J&J image

J&J says revived OTC brands are ‘winning the hearts of consumers’

July 19, 2013
Manufacturing and Production, Sales and Marketing Control, FDA, GDP, J&J, JJ, OTC

Johnson & Johnson doesn’t usually provide specific financials for its over-the-counter pharmaceuticals business, but did so for the first time …

News
Euro image

EU publishes final GDP guidelines

March 19, 2013
Manufacturing and Production EC, EU, GDP

The European Commission has published the final version of its long-awaited guidelines on Good Distribution Practice (GDP), replacing an earlier …

News

Excipient certification project moves forward

December 4, 2012
Manufacturing and Production DEG, EXCiPACT, GDP, GMP

The EXCiPACT certification scheme for pharmaceutical excipients has taken a step closer to fruition with agreements now in place with …

News

Growth in health spending ‘grinds to a halt’

June 28, 2012
Business Services, Sales and Marketing Financial, GDP, OECD, growth, pharma

Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term …

News

Excipient certification scheme launches

February 13, 2012
Manufacturing and Production EXCiPACT, GDP, GMP, manufacturing

A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …

News

European falsified meds directive: implications for manufacturers

June 7, 2011
Manufacturing and Production APIs, GDP, GMP, excipients, pharma manufacturing

The Council of the European Union gave its backing to the new Directive on Falsified Medicines on May 27, setting …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024